Granted Patent
B2
US 12,286,645 · App. 17/161,269 · Granted Apr 29, 2025
Generation of induced pluripotent stem cells (IPSCs) with GLUT2 mutation or FOXA2 deletion, methods of preparing same, and methods of using same
Assignee:
HAMAD BIN KHALIFA UNIVERSITY
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present disclosure generally relates to the method of generating human induced pluripotent stem cells (hiPSC) from patients with either heterozygous deletion of the FOX2A gene or GLUT2 (SLC2A2) gene mutations. The methods disclosed herein generate human cell models for diabetes, Fanconi Bickel Syndrome (FBS), dysmporphic features, growth hormone deficiency, central hypothyroidism, and related disorders. The methods disclosed herein generate patient-specific iPSC cell lines that could be used by researchers to perform mechanistic studies, drug screening, and understanding the role of GLUT2 or FOXA2 in specific human cell types.
Claims (7)
1. A method of generating human induced pluripotent stem cells (hiPSCs) with a mutation in both copies of a GLUT2 (SLC2A2) gene comprising:
obtaining peripheral blood mononuclear cells (PBMCs) from a patient with diabetes mellitus and Fanconi-Bickel syndrome;
determining whether the PBMCs have a mutation in intron 5 in both copies of the GLUT2 (SLC2A2);
selecting the PBMCs having the mutation in intron 5 in both copies of the GLUT2 (SLC2A2) gene; and
exposing the PBMCs from the patient to a means for inducing pluripotency by transducing with vectors capable of conferring expression of OCT4, Sox2, Klf4, and c-Myc,
wherein the mutation in intron 5 of the GLUT2 (SLC2A2) gene is a c.613-7T>G:IVS5-7T>G mutation.
2. The method of claim 1 , wherein the generated hiPSCs are for researching the development and pathologies of diabetes and Fanconi-Bickel syndrome.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 17, 2025
From: QATAR FOUNDATION FOR EDUCATION, SCIENCE & COMMUNITY DEVELOPMENT
To: HAMAD BIN KHALIFA UNIVERSITY
Reel/Frame 069936/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 9, 2021
From: ABDELALIM, ESSAM M.; ELSAYED, AHMED K.; HUSSAIN, KHALID
To: QATAR FOUNDATION FOR EDUCTION, SCIENCE AND COMMUNITY DEVELOPMENT
Reel/Frame 055196/0405 →
Continuity (2)
Provisional Application
62966875
· Jan 28, 2020
References Cited (33)
US 20190282710A1
· Fussenegger et al.
· 2019
[cited by applicant]
CN 109563487A
· 2019
[cited by applicant]
Sharari (Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi-Bickel Syndrome. Biomedicine, vol. 10, Aug. 2022) (Year: 2022).
[cited by examiner]
Griscelli (Generation an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11(KCNJ11) …
[cited by examiner]
Dweikat (Fanconi-Bickel syndrome in two Palestinian children: marked phenotypic variability with identical mutation. BMC Research Notes, vol. 9, Aug. 2016). (Year: 2016).
[cited by examiner]
NM_00040.2 (Year: 2000).
[cited by examiner]
Santer et al (The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet (2002) 110 :21-29) (Year: 2002).
[cited by examiner]
NM 000340.2 (Year: 2018).
[cited by examiner]
Abbasi et al., “Segregation of a Novel Homozygous 6 Nucleotide Deletion in GLUT2 Gene in a Fanconi-Bickel Syndrome Family”, Gene (2015), 557(1), pp. 103-105.
[cited by applicant]
Al-Haggar et al., “Mutation Analysis of the GLUT2 Gene in Three Unrelated Egyptian Families with Fanconi-Bickel Syndrome: Revisited Gene Atlas for Renumbering”, Clinical and Experimental Nephrology (2012), 16(4), pp. 60…
[cited by applicant]
Ang et al., “HNF-3β is Essential for Node and Notochord Formation in Mouse Development”, Cell (1994), 78(4), pp. 561-574. (Abstract only).
[cited by applicant]
Barroso et al., “Candidate Gene Association Study in Type 2 Diabetes Indicates a Role for Genes Involved in β-Cell Function as Well as Insulin Action”, PLoS Biology (2003), 1(1), pp. 41-55.
[cited by applicant]
Elsayed et al., “An Induced Pluripotent Stem Cell Line Derived from a Patient with Neonatal Diabetes and Fanconi-Bickel Syndrome Caused by a Homozygous Mutation in the SLC2A2 Gene”, Stem Cell Research (2021), 54(10), pp…
[cited by applicant]
Elsayed et al., “Generation of a Human Induced Pluripotent Stem Cell Line (QBRli009-A) from a Patient with a Heterozygous Deletion of FOXA2”, Stem Cell Research (2020), vol. 42, pp. 1-5.
[cited by applicant]
Enogieru et al., “Functional and Structural Analysis of Rare SLC2A2 Variants Associated with Fanconi-Bickel Syndrome and Metabolic Traits”, Human Mutation (2019), 40(7), pp. 983-995.
[cited by applicant]
Gao et al., “Foxa1 and Foxa2 Maintain the Metabolic and Secretory Features of the Mature β-cell”, Molecular Endocrinology (2010), 24(8), pp. 1594-1604.
[cited by applicant]
Gaulton et al., “Genetic Fine Mapping and Genomic Annotation Defines Causal Mechanisms at Type 2 Diabetes Susceptibility Loci”, Nature Genetics (2015), 47(12), pp. 1415-1425.
[cited by applicant]
Guillam et al., “Early Diabetes and Abnormal Postnatal Pancreatic Islet Development in Mice Lacking Glut-2”, Nature Genetics (1997), 17(3), pp. 327-330. (Abstract only).
[cited by applicant]
Heddad-Masson et al., “Foxa1 and Foxa2 Regulate α-Cell Differentiation, Glucagon Biosynthesis, and Secretion”, Endocrinology (2014), 155(10), pp. 3781-3792.
[cited by applicant]
Kaestner et al., “Inactivation of the Winged Helix Transcription Factor HNF3α Affects Glucose Homeostasis and Islet Glucagon Gene Expression in vivo”, Genes & Development (1999), 13(4), pp. 495-504.
[cited by applicant]
Lantz et al., “Foxa2 Regulates Multiple Pathways of Insulin Secretion”, The Journal of Clinical Investigation (2004), 114 (4), pp. 512-520.
[cited by applicant]
Laukkanen et al., “Polymorphisms in the SLC2A2 (GLUT2) Gene are Associated with the Conversion from Impaired Glucose Tolerance to Type 2 Diabetes: The Finnish Diabetes Prevention Study”, Diabetes (2005), 54(7), pp. 2256…
[cited by applicant]
Mannstadt et al., “Fanconi-Bickel Syndrome and Autosomal Recessive Proximal Tubulopathy with Hypercalciuria (ARPTH) are Allelic Variants Caused by GLUT2 Mutations”, The Journal of Clinical Endocrinology & Metabolism (20…
[cited by applicant]
Møller et al., “Studies of Genetic Variability of the Glucose Transporter 2 Promoter in Patients with Type 2 Diabetes Mellitus”, The Journal of Clinical Endocrinology & Metabolism (2001), 86(5), pp. 2181-2186.
[cited by applicant]
Sansbury et al., “SLC2A2 Mutations Can Cause Neonatal Diabetes, Suggesting GLUT2 May Have a Role in Human Insulin Secretion”, Diabetologia (2012), 55(9), pp. 2381-2385.
[cited by applicant]
Santer et al., “Fanconi-Bickel Syndrome—A Congenital Defect of Facilitative Glucose Transport”, Current Molecular Medicine (2002), 2(2), pp. 213-227. (Abstract only).
[cited by applicant]
Scott et al., “Large-Scale Association Analyses Identify New Loci Influencing Glycemic Traits and Provide Insight into the Underlying Biological Pathways”, Nature Genetics (2012), 44(9), pp. 991-1005.
[cited by applicant]
Segev et al., “The Expression of the Class 1 Glucose Transporter Isoforms in Human Embryonic Stem Cells, and the Potential Use of GLUT2 as a Marker for Pancreatic Progenitor Enrichment”, Stem Cells and Development (2012…
[cited by applicant]
Shih et al., “Impaired Glucose Homeostasis and Neonatal Mortality in Hepatocyte Nuclear Factor 3α-Deficient Mice”, Proceedings of the National Academy of Sciences of the United States of America (1999), 96(18), pp. 1015…
[cited by applicant]
Soranzo et al., “Common Variants at 10 Genomic Loci Influence Hemoglobin A1C Levels via Glycemic and Nonglycemic Pathways”, Diabetes (2010), 59(12), pp. 3229-3239.
[cited by applicant]
Stanley, C.A., “Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders”, The Journal of Clinical Endocrinology and Metabolism (2016), 101(3), pp. 815-826.
[cited by applicant]
Weinstein et al., “The Winged-Helix Transcription Factor HNF-3β is Required for Notochord Development in the Mouse Embryo”, Cell (1994), 78(4), pp. 575-588. (Abstract only).
[cited by applicant]
Willmann et al., “The Global Gene Expression Profile of the Secondary Transition During Pancreatic Development”, Mechanisms of Development (2016), vol. 139, pp. 51-64.
[cited by applicant]